CRNOB (CRNOB) News
Track canonical SquawkNews coverage tagged to CRNOB, CRNOB. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 5 indexed stories across 4 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Cereno Scientific Reports Positive Results From Study
Cereno Scientific AB OMXSTO:CRNO_B
NEWS | Sep 25, 2026, 02:33 PM UTC
L
Cereno Scientific AB (CRNO_B) Posts Positive CS014 PK-Bridging, Plans Direct Path to Phase IIb
Cereno Scientific reported positive topline Phase I PK-bridging results for CS014 versus VPA, supporting its plan to advance directly to a Phase IIb trial in PH-ILD, subject to FDA review. IND submission is planned for Q
REGULATION | Sep 25, 2026, 08:14 AM UTC
L
Cereno Scientific CEO to participate in H.C. Wainwright conference
Cereno Scientific said CEO Sten R. Sörensen will participate at the H.C. Wainwright 28th Annual Global Investment Conference in New York.
EQUITY | Sep 09, 2026, 05:30 AM UTC
L
Cereno Scientific to take part in Nordic Life Science Days 2026
Cereno Scientific said CEO Sten R. Sörensen and Director — Business Development & Strategy Megha Ranjan will participate at Nordic Life Science Days 2026 as clinical programs advance.
EQUITY | Sep 08, 2026, 05:45 AM UTC
L
Cereno Scientific Q2 Net Sales Sek 0
Cereno Scientific Q2 Net Sales Sek 0
EQUITY | Aug 26, 2026, 06:54 AM UTC